Dr. Robert C. Sergott, MD
Ophthalmology (Neuro-ophthalmology Physician)
- Medicare participating
At a glance
- Medical school
- Johns Hopkins University School of Medicine (1975)
- Years since graduation
- 51
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 536
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1975Medical school: Johns Hopkins University School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neuro-ophthalmology Physician primary
PA license MD018980E -
Ophthalmology Physician
PA license MD018980E
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Hospital of Univ of Pennsylvania Philadelphia, PA
- Christiana Hospital Newark, DE
- Thomas Jefferson University Hospital Philadelphia, PA
- Main Line Hospital Lankenau Wynnewood, PA
Medical groups
- Wills Eye Ophthalmology Clinic, Inc (147 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 536
- Services billed
- 3,626
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient complete exam of visual system | 183 | 181 |
| Established patient problem focused exam of visual system | 172 | 130 |
| Imaging of optic nerve | 164 | 151 |
| Exam of visual field with extended testing | 163 | 151 |
| Ultrasound of both sides of head and neck blood flow | 160 | 157 |
| New patient office or other outpatient visit, 45-59 minutes | 125 | 125 |
| Exam to measure eye deviation and range of motion | 101 | 83 |
| New patient office or other outpatient visit, 60-74 minutes | 58 | 58 |
| Established patient office or other outpatient visit, 30-39 minutes | 30 | 30 |
| Ultrasound of within the brain blood flow | 28 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 16 companies reported 199 payments worth $170,654 in total to this clinician.
| Amgen Inc. | $96,719 |
|---|---|
| Mallinckrodt Hospital Products Inc. | $38,610 |
| Alexion Pharmaceuticals, Inc. | $17,482 |
| AstraZeneca UK Limited | $13,022 |
| Argenx US, Inc. | $2,729 |
| Catalyst Pharmaceuticals, Inc. | $1,200 |
| Novartis Pharmaceuticals Corporation | $238 |
| EMD Serono, Inc. | $205 |
| Compensation for services other than consulting (speaking, faculty) | $116,638 |
|---|---|
| Consulting Fee | $32,050 |
| Travel and Lodging | $15,883 |
| Food and Beverage | $4,884 |
| Honoraria | $1,200 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. Nov 12, 2025 | Consulting Fee ACTHAR · IMMUNOLOGY | $7,740 |
| Mallinckrodt Hospital Products Inc. Jun 4, 2025 | Compensation for services other than consulting (speaking, faculty) ACTHAR · IMMUNOLOGY | $7,600 |
| Mallinckrodt Hospital Products Inc. Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) ACTHAR · IMMUNOLOGY | $7,600 |
| Mallinckrodt Hospital Products Inc. Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) ACTHAR · IMMUNOLOGY | $7,600 |
| AstraZeneca UK Limited Aug 22, 2025 | Consulting FeeCompany’s descriptionResearch Related Service | $7,518 |
| Mallinckrodt Hospital Products Inc. Nov 25, 2025 | Compensation for services other than consulting (speaking, faculty) ACTHAR · IMMUNOLOGY | $5,700 |
| AstraZeneca UK Limited Jun 6, 2025 | Consulting Fee | $4,967 |
| Amgen Inc. Jan 7, 2025 | Consulting Fee UPLIZNA · Inflammation/Rare Disease | $4,129 |
| Amgen Inc. Mar 27, 2025 | Compensation for services other than consulting (speaking, faculty) TEPEZZA · Inflammation/Rare Disease | $3,575 |
| Amgen Inc. Jan 7, 2025 | Consulting Fee UPLIZNA · Inflammation/Rare Disease | $3,539 |
All 98 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca UK Limited Dec 18, 2025 | Consulting FeeCompany’s descriptionResearch Related Service | $537 |
| Catalyst Pharmaceuticals, Inc. Dec 11, 2025 | Honoraria FIRDAPSE · NEUROLOGY | $1,200 |
| Amgen Inc. Dec 4, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,300 |
| Amgen Inc. Dec 4, 2025 | Compensation for services other than consulting (speaking, faculty) | $550 |
| Amgen Inc. Dec 1, 2025 | Travel and Lodging travel to Allentown, PA · in-kind | $661 |
| Mallinckrodt Hospital Products Inc. Nov 25, 2025 | Compensation for services other than consulting (speaking, faculty) ACTHAR · IMMUNOLOGY | $5,700 |
| Amgen Inc. Nov 24, 2025 | Compensation for services other than consulting (speaking, faculty) UPLIZNA · Inflammation/Rare Disease | $3,300 |
| Amgen Inc. Nov 24, 2025 | Compensation for services other than consulting (speaking, faculty) UPLIZNA · Inflammation/Rare Disease | $1,100 |
| Amgen Inc. Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,300 |
| Amgen Inc. Nov 20, 2025 | Compensation for services other than consulting (speaking, faculty) | $550 |
| Amgen Inc. Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,300 |
| Amgen Inc. Nov 19, 2025 | Compensation for services other than consulting (speaking, faculty) | $550 |
| Mallinckrodt Hospital Products Inc. Nov 19, 2025 | Travel and Lodging ACTHAR · IMMUNOLOGY · travel to PHILADELPHIA, PA | $96.00 |
| Mallinckrodt Hospital Products Inc. Nov 19, 2025 | Travel and Lodging ACTHAR · IMMUNOLOGY · travel to PHILADELPHIA, PA | $27.30 |
| Amgen Inc. Nov 18, 2025 | Travel and Lodging travel to Margate, NJ · in-kind | $848 |
| Amgen Inc. Nov 18, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to Birmingham, AL | $56.00 |
| Amgen Inc. Nov 18, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to Birmingham, AL | $46.38 |
| Amgen Inc. Nov 18, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to Birmingham, AL | $27.30 |
| Amgen Inc. Nov 17, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,300 |
| Amgen Inc. Nov 17, 2025 | Travel and Lodging travel to Paramus, NJ · in-kind | $1,083 |
| Amgen Inc. Nov 17, 2025 | Travel and Lodging travel to Columbia, MD · in-kind | $959 |
| Amgen Inc. Nov 17, 2025 | Compensation for services other than consulting (speaking, faculty) | $550 |
| Alexion Pharmaceuticals, Inc. Nov 15, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Philadelphia, PA | $16.52 |
| Alexion Pharmaceuticals, Inc. Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty) ULTOMIRIS · Rare Disease Company’s descriptionSpeaker Fee | $3,350 |
| Mallinckrodt Hospital Products Inc. Nov 12, 2025 | Consulting Fee ACTHAR · IMMUNOLOGY | $7,740 |
| Alexion Pharmaceuticals, Inc. Nov 5, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Philadelphia, PA | $47.88 |
| Mallinckrodt Hospital Products Inc. Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) ACTHAR · IMMUNOLOGY | $7,600 |
| Mallinckrodt Hospital Products Inc. Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) ACTHAR · IMMUNOLOGY | $7,600 |
| Amgen Inc. Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) UPLIZNA · Inflammation/Rare Disease | $3,300 |
| Amgen Inc. Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) UPLIZNA · Inflammation/Rare Disease | $3,300 |
| Amgen Inc. Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,300 |
| Amgen Inc. Oct 30, 2025 | Compensation for services other than consulting (speaking, faculty) UPLIZNA · Inflammation/Rare Disease | $2,200 |
| Amgen Inc. Oct 29, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to Montgomery, AL | $225 |
| Amgen Inc. Oct 29, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to Montgomery, AL | $56.00 |
| Amgen Inc. Oct 29, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to Montgomery, AL | $27.30 |
| Amgen Inc. Oct 24, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to TUSCALOOSA, AL · in-kind | $781 |
| Alexion Pharmaceuticals, Inc. Oct 23, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $3,350 |
| Amgen Inc. Oct 22, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to TUSCALOOSA, AL · in-kind | $505 |
| Alexion Pharmaceuticals, Inc. Oct 16, 2025 | Compensation for services other than consulting (speaking, faculty) ULTOMIRIS · Rare Disease Company’s descriptionSpeaker Fee | $3,350 |
| Amgen Inc. Oct 14, 2025 | Compensation for services other than consulting (speaking, faculty) UPLIZNA · Inflammation/Rare Disease | $3,300 |
| Amgen Inc. Oct 14, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,300 |
| Amgen Inc. Oct 14, 2025 | Compensation for services other than consulting (speaking, faculty) UPLIZNA · Inflammation/Rare Disease | $3,300 |
| Amgen Inc. Oct 14, 2025 | Compensation for services other than consulting (speaking, faculty) UPLIZNA · Inflammation/Rare Disease | $2,200 |
| Amgen Inc. Oct 13, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to Montgomery, AL · in-kind | $2,635 |
| Mallinckrodt Hospital Products Inc. Oct 11, 2025 | Travel and Lodging ACTHAR · IMMUNOLOGY · travel to NASHVILLE, TN · in-kind | $139 |
| Mallinckrodt Hospital Products Inc. Oct 11, 2025 | Travel and Lodging ACTHAR · IMMUNOLOGY · travel to NASHVILLE, TN · in-kind | $64.24 |
| Mallinckrodt Hospital Products Inc. Oct 10, 2025 | Travel and Lodging ACTHAR · IMMUNOLOGY · travel to NASHVILLE, TN · in-kind | $567 |
| Mallinckrodt Hospital Products Inc. Oct 10, 2025 | Travel and Lodging ACTHAR · IMMUNOLOGY · travel to NASHVILLE, TN · in-kind | $352 |
| Mallinckrodt Hospital Products Inc. Oct 10, 2025 | Travel and Lodging ACTHAR · IMMUNOLOGY · travel to NASHVILLE, TN · in-kind | $263 |
| Alexion Pharmaceuticals, Inc. Oct 7, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Newtown, PA | $53.06 |
| Alexion Pharmaceuticals, Inc. Oct 7, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Newtown, PA | $4.53 |
| Alexion Pharmaceuticals, Inc. Sep 18, 2025 | Compensation for services other than consulting (speaking, faculty) ULTOMIRIS · Rare Disease Company’s descriptionSpeaker Fee | $3,350 |
| Alexion Pharmaceuticals, Inc. Sep 18, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $3,350 |
| Amgen Inc. Sep 12, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to TUSCALOOSA, AL · in-kind | $817 |
| Alexion Pharmaceuticals, Inc. Sep 11, 2025 | Travel and Lodging ULTOMIRIS · Rare Disease · travel to Malvern, PA | $22.54 |
| Alexion Pharmaceuticals, Inc. Sep 10, 2025 | Travel and Lodging travel to Philadelphia, PA | $53.98 |
| Alexion Pharmaceuticals, Inc. Sep 10, 2025 | Travel and Lodging travel to Haverford, PA | $48.95 |
| Amgen Inc. Sep 4, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to Montgomery, AL · in-kind | $781 |
| AstraZeneca UK Limited Aug 22, 2025 | Consulting FeeCompany’s descriptionResearch Related Service | $7,518 |
| Amgen Inc. Aug 21, 2025 | Compensation for services other than consulting (speaking, faculty) | $688 |
| AstraZeneca UK Limited Jun 6, 2025 | Consulting Fee | $4,967 |
| Amgen Inc. Jun 6, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to ATLANTA, GA · in-kind | $515 |
| Amgen Inc. Jun 6, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to ATLANTA, GA · in-kind | $156 |
| Mallinckrodt Hospital Products Inc. Jun 4, 2025 | Compensation for services other than consulting (speaking, faculty) ACTHAR · IMMUNOLOGY | $7,600 |
| Amgen Inc. May 22, 2025 | Travel and Lodging travel to Mobile, AL | $495 |
| Amgen Inc. May 22, 2025 | Travel and Lodging travel to Mobile, AL | $56.00 |
| Amgen Inc. May 22, 2025 | Travel and Lodging travel to Mobile, AL | $42.54 |
| Amgen Inc. May 22, 2025 | Travel and Lodging travel to Mobile, AL | $24.08 |
| Amgen Inc. May 16, 2025 | Compensation for services other than consulting (speaking, faculty) | $3,300 |
| Amgen Inc. May 13, 2025 | Consulting Fee TAVNEOS · Inflammation | $670 |
| Amgen Inc. Apr 15, 2025 | Travel and Lodging TEPEZZA · Inflammation/Rare Disease · travel to DALLAS, TX | $76.00 |
| Amgen Inc. Apr 15, 2025 | Travel and Lodging TEPEZZA · Inflammation/Rare Disease · travel to DALLAS, TX | $18.55 |
| Amgen Inc. Mar 27, 2025 | Compensation for services other than consulting (speaking, faculty) TEPEZZA · Inflammation/Rare Disease | $3,575 |
| Amgen Inc. Mar 27, 2025 | Compensation for services other than consulting (speaking, faculty) TEPEZZA · Inflammation/Rare Disease | $2,750 |
| Amgen Inc. Mar 8, 2025 | Travel and Lodging TEPEZZA · Inflammation/Rare Disease · travel to DALLAS, TX · in-kind | $678 |
| Amgen Inc. Mar 8, 2025 | Travel and Lodging TEPEZZA · Inflammation/Rare Disease · travel to DALLAS, TX · in-kind | $304 |
| Amgen Inc. Mar 7, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to PHOENIX, AZ | $465 |
| Amgen Inc. Mar 7, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to PHOENIX, AZ | $120 |
| Amgen Inc. Mar 4, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to PHOENIX, AZ · in-kind | $206 |
| Amgen Inc. Feb 7, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to ENCINO, CA | $346 |
| Amgen Inc. Feb 7, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to PHOENIX, AZ | $67.68 |
| Amgen Inc. Feb 3, 2025 | Compensation for services other than consulting (speaking, faculty) UPLIZNA · Inflammation/Rare Disease | $3,300 |
| Amgen Inc. Feb 3, 2025 | Compensation for services other than consulting (speaking, faculty) UPLIZNA · Inflammation/Rare Disease | $3,300 |
| Amgen Inc. Feb 3, 2025 | Compensation for services other than consulting (speaking, faculty) UPLIZNA · Inflammation/Rare Disease | $3,300 |
| Amgen Inc. Feb 3, 2025 | Compensation for services other than consulting (speaking, faculty) UPLIZNA · Inflammation/Rare Disease | $2,200 |
| Amgen Inc. Jan 29, 2025 | Compensation for services other than consulting (speaking, faculty) UPLIZNA · Inflammation/Rare Disease | $2,475 |
| Mallinckrodt Hospital Products Inc. Jan 28, 2025 | Travel and Lodging ACTHAR · IMMUNOLOGY · travel to PORTSMOUTH, NH | $84.00 |
| Mallinckrodt Hospital Products Inc. Jan 28, 2025 | Travel and Lodging ACTHAR · IMMUNOLOGY · travel to PORTSMOUTH, NH | $26.80 |
| Amgen Inc. Jan 15, 2025 | Travel and Lodging travel to DALLAS, TX | $68.76 |
| Argenx US, Inc. Jan 10, 2025 | Compensation for services other than consulting (speaking, faculty) VYVGART · Immunology | $2,500 |
| Argenx US, Inc. Jan 10, 2025 | Travel and Lodging VYVGART · Immunology · travel to Philadelphia, PA | $72.80 |
| Amgen Inc. Jan 7, 2025 | Consulting Fee UPLIZNA · Inflammation/Rare Disease | $4,129 |
| Amgen Inc. Jan 7, 2025 | Consulting Fee UPLIZNA · Inflammation/Rare Disease | $3,539 |
| Amgen Inc. Jan 7, 2025 | Consulting Fee UPLIZNA · Inflammation/Rare Disease | $2,949 |
| Amgen Inc. Jan 6, 2025 | Travel and Lodging UPLIZNA · Inflammation/Rare Disease · travel to PHOENIX, AZ · in-kind | $736 |
| Amgen Inc. Jan 3, 2025 | Travel and Lodging TEPEZZA · Inflammation/Rare Disease · travel to PHILADELPHIA, PA | $36.00 |
| Amgen Inc. Jan 3, 2025 | Travel and Lodging TEPEZZA · Inflammation/Rare Disease · travel to PHILADELPHIA, PA | $14.74 |
| Amgen Inc. Jan 3, 2025 | Travel and Lodging TEPEZZA · Inflammation/Rare Disease · travel to PHILADELPHIA, PA | $10.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $1,500 in research payments for these studies, mostly to the institutions running them.
- Observational evaluation of Effectiveness And Patient-Reported outcomes (PROs) in suboptimally controlled patients previously taking oral or infusion disease-modifying drugs (DMDs) for relapsing forms of multiple scle…
EMD Serono, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.